Thomas P Green

  • 3033 Citations
1979 …2019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

I am interested in using quantitative pharmacologic approaches (modeling and simulation) to improve the understanding of drug disposition and effects in children. Pharmacometric interpretation of both population and clinical trial data can lead to more efficacious and safer treatments as well as provide guidance for the design of efficient, definitive pediatric clinical trials.

Pharmacometrics, Pediatric Clinical Pharmacology

Pediatric Critical Care Medicine, Pediatric Pulmonary Medicine

Certifications and Licenses

Pediatric Pulmonology
Pediatric Critical Care Medicine
Pediatrics

Training Experience

1975Internship, University of Minnesota Medical Center
1977Residency, University of Minnesota Medical Center
1979Fellowship, University of Minnesota Medical Center
1994Fellowship, University of North Carolina School of Medicine
1994Fellowship, University of Minnesota Medical Center

Education/Academic qualification

MD, Stanford University

… → 1974

Research interests

  • Clinical Pharmacology
  • Critical Care
  • Pediatrics
  • Pharmacokinetics
  • Pharmacology
  • Respiratory Diseases

Fingerprint Dive into the research topics where Thomas P Green is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Furosemide Medicine & Life Sciences
Extracorporeal Membrane Oxygenation Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Pediatric Intensive Care Units Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Diuretics Medicine & Life Sciences
Critical Care Medicine & Life Sciences
Kidney Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1979 2019

2 Citations (Scopus)

Hydroxychloroquine levels throughout pregnancies complicated by rheumatic disease: Implications for maternal and neonatal outcomes

Balevic, S. J., Cohen-Wolkowiez, M., Eudy, A. M., Green, T. P., Schanberg, L. E. & Clowse, M. E. B., Jan 1 2019, In : Journal of Rheumatology. 46, 1, p. 57-63 7 p.

Research output: Contribution to journalArticle

Hydroxychloroquine
Rheumatic Diseases
Mothers
Pregnancy
Systemic Lupus Erythematosus

Pharmacokinetics of Hydroxychloroquine in Pregnancies with Rheumatic Diseases

Balevic, S. J., Green, T. P., Clowse, M. E. B., Eudy, A. M., Schanberg, L. E. & Cohen-Wolkowiez, M., Apr 4 2019, In : Clinical Pharmacokinetics. 58, 4, p. 525-533 9 p.

Research output: Contribution to journalArticle

Hydroxychloroquine
Rheumatic Diseases
Pharmacokinetics
Pregnancy
Postpartum Period
1 Citation (Scopus)

A pharmacokinetic model for amiodarone in infants developed from an opportunistic sampling trial and published literature data

Dallefeld, S. H., Atz, A. M., Yogev, R., Sullivan, J. E., Al-Uzri, A., Mendley, S. R., Laughon, M., Hornik, C. P., Melloni, C., Harper, B., Lewandowski, A., Mitchell, J., Wu, H., Green, T. P. & Cohen-Wolkowiez, M., Jun 1 2018, In : Journal of Pharmacokinetics and Pharmacodynamics. 45, 3, p. 419-430 12 p.

Research output: Contribution to journalArticle

Amiodarone
Pharmacokinetics
Population
Half-Life
Ventricular Fibrillation

Low Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes

Balevic, SK., Cohen-Wolkowiez, M., Eudy, AM., Green, TP., Schanberg, LE. & Clouse, MEB., Nov 1 2018, In : Journal of Rheumatology. 45, p. 180158 1 p.

Research output: Contribution to journalArticle

38 Citations (Scopus)

Codeine: Time to say no

Tobias, J. D., Green, T. P. & Coté, C. J., Oct 1 2016, In : Pediatrics. 138, 4, e20162396.

Research output: Contribution to journalArticle

Codeine
Antitussive Agents
Analgesics
Opioid Analgesics
Cytochrome P-450 CYP2D6